TESARO, INC.

Profile

Company Names

TESARO, INC.

Addresses

1000 WINTER STREET, SUITE 3300, WALTHAM, MA 02451

1000 WINTER STREET, SUITE 3300, WALTHAM, MA 02451

309 WAVERLEY OAKS ROAD, SUITE #101, WALTHAM, MA 02452

51 FOLLEN ROAD, LEXINGTON, MA 02421

Phone Numbers

(339) 970-0900
339-970-0900
952-212-4713

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$254,999,875.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2016-04-05 
$49,999,960.00 
$49,999,960.00 
$0.00 
Equity 
3
2016-02-24 
$154,999,915.00 
$154,999,915.00 
$0.00 
Equity 
2
2011-06-06 
$40,000,000.00 
$101,000,000.00 
$61,000,000.00 
Equity 
1
2010-05-10 
$10,000,000.00 
$20,000,000.00 
$10,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LAWRENCE 
M. 
ALLEVA 
DIRECTOR
GLOBALLOGIC INC   |  TESARO, INC.
JAMES 
O. 
ARMITAGE 
DIRECTOR
TESARO, INC.   |  CARDIFF ONCOLOGY, INC.   |  TROVAGENE, INC.
GRANT 
C. 
BOGLE 
EXECUTIVE OFFICER
TESARO, INC.
EARL 
M. 
COLLIER, JR. 
DIRECTOR
ARSENAL VASCULAR, INC.   |  CAPRICOR INC   |  480 BIOMEDICAL, INC.   |  TRANSMEDICS, INC.   |  TESARO, INC.
JOSEPH 
L. 
FARMER 
EXECUTIVE OFFICER
TESARO, INC.
JEFFREY 
H. 
HANKE 
EXECUTIVE OFFICER
TESARO, INC.
MARY 
LYNNE 
HEDLEY 
EXECUTIVE OFFICER, DIRECTOR
TESARO, INC.
MARY LYNNE 
 
HEDLEY 
EXECUTIVE OFFICER, DIRECTOR
TESARO, INC.   |  MILLENDO THERAPEUTICS, INC.
MARTIN 
H. 
HUBER 
EXECUTIVE OFFICER
TESARO, INC.
DAVID 
 
MOTT 
DIRECTOR
3-V BIOSCIENCES, INC.   |  TESARO, INC.   |  ARDELYX, INC.   |  ZYNGENIA, INC.   |  OMTHERA PHARMACEUTICALS, INC.   |  MERSANA THERAPEUTICS INC   |  CYDAN, LLC   |  EDIMER PHARMACEUTICALS, INC.   |  PROSENSA HOLDING N.V.   |  ADAPTIMMUNE LTD   |  MERSANA THERAPEUTICS, INC.   |  XTUIT PHARMACEUTICALS, INC.   |  IMARA INC.   |  COMPLEXA INC.   |  CYDAN II, INC.   |  TIBURIO THERAPEUTICS INC.
DAVID 
M. 
MOTT 
DIRECTOR
NEW ENTERPRISE ASSOCIATES 13 LP   |  ZOSANO PHARMA INC   |  NEW ENTERPRISE ASSOCIATES 14, L.P.   |  NEA 15 OPPORTUNITY FUND, L.P.   |  TESARO, INC.   |  NEA BH SPV, L.P.
LEON 
O. 
MOULDER JR. 
EXECUTIVE OFFICER, DIRECTOR
TESARO, INC.
LEON 
O. 
MOULDER, JR. 
EXECUTIVE OFFICER, DIRECTOR
TESARO, INC.   |  INTERIUS BIOTHERAPEUTICS, INC.   |  DIANTHUS THERAPEUTICS, INC.   |  NAVROGEN, INC.   |  PRAEVENTIX, INC.   |  ZENAS BIOPHARMA (CAYMAN) LTD   |  NAVROGEN INC.   |  ZENAS BIOPHARMA, INC.
GARRY 
A. 
NICHOLSON 
DIRECTOR
TESARO, INC.   |  SQZ BIOTECHNOLOGIES CO
ARNOLD 
 
ORONSKY 
DIRECTOR
APPLIED GENETIC TECHNOLOGIES CORP   |  ARCION THEREAPEUTICS INC   |  DRAIS PHARMACEUTICALS INC   |  ARCION THERAPEUTICS, INC.   |  USDS, INC.   |  MACROGENICS INC   |  TESARO, INC.   |  TELSAR PHARMA, INC.   |  SELDAR PHARMA, INC.   |  INTEGRATED DIAGNOSTICS, INC.   |  POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  PMV PHARMACEUTICALS, INC.   |  CENTREXION THERAPEUTICS CORP
ARNOLD 
L. 
ORONSKY 
DIRECTOR
ANESIVA, INC.   |  RADIORX, INC.   |  CENTREXION CORP   |  TESARO, INC.   |  CENTREXION THERAPEUTICS CORP
KAVITA 
 
PATEL 
DIRECTOR
TESARO, INC.   |  RADIOLOGY PARTNERS HOLDINGS, LLC   |  PERSONAL GENOME DIAGNOSTICS INC.   |  ARCELLX, INC.
TIMOTHY 
R. 
PEARSON 
EXECUTIVE OFFICER
TESARO, INC.
RICHARD 
J. 
RODGERS 
EXECUTIVE OFFICER
TESARO, INC.   |  OCUPHIRE PHARMA, INC.
BETH 
 
SEIDENBERG 
DIRECTOR
3-V BIOSCIENCES, INC.   |  HX DIAGNOSTICS INC   |  IPIERIAN, INC.   |  REDBRICK HEALTH CORP   |  TESARO, INC.   |  AUXOGYN INC   |  PRACTICE FUSION INC   |  SANTA MARIA BIOTHERAPEUTICS, INC.   |  PINTA BIOTHERAPEUTICS, INC.   |  NINA BIOTHERAPEUTICS, INC.   |  BREATHE TECHNOLOGIES INC   |  AUXOGYN, INC.   |  FLEXUS BIOSCIENCES, INC.   |  LIVONGO HEALTH, INC.   |  PROGYNY, INC.   |  CELL DESIGN LABS, INC.   |  FLX BIO, INC.   |  HIXME INSURANCE SOLUTIONS, INC.   |  KINSA INC.   |  BREATHE ACQUISITION CORP.   |  BREATHE TECHNOLOGIES, INC.   |  WESTLAKE BIOPARTNERS FUND I, L.P.   |  RAPT THERAPEUTICS, INC.   |  TMUNITY THERAPEUTICS, INC.   |  SAGIMET BIOSCIENCES INC.   |  VERA THERAPEUTICS, INC.   |  WESTLAKE BIOPARTNERS OPPORTUNITY FUND I, L.P.   |  ARSENAL BIOSCIENCES, INC.   |  LATIGO BIOTHERAPEUTICS, INC.   |  STAR THERAPEUTICS LLC
PAUL 
 
WALKER 
DIRECTOR
TESARO, INC.   |  GFI SOFTWARE S.A.   |  LOGICNOW S.A.   |  SPECTRAL MEDICAL INC.   |  TRACON PHARMACEUTICALS, INC.   |  ALLAKOS INC.   |  UNQORK INC.   |  VALSTRO HOLDINGS LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-04-18
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2016-04-05 
2016-03-10
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2016-02-24 
2011-06-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-06-06 
2010-05-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#